Skip to main content
. Author manuscript; available in PMC: 2024 Jan 5.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2023 Jul 5;32(7):976–985. doi: 10.1158/1055-9965.EPI-23-0102

Table 1.

Characteristics of postmenopausal women not using hormone therapy whose plasma hormone levels were measured in the Nurses’ Health Study (n=1976).

Characteristic All participants (n=1976)
Age at blood draw, y (Mean, SD) 61.4 (4.7)
Age at menarche, y (Mean, SD) 12.7 (1.4)
Irregular cycles (n, %) 252 (13.6%)
Parous (n, %) 1892 (95.8%)
Parity (Mean, SD)* 3.5 (1.7)
Ever breastfed (n, %) 1275 (64.5%)
Duration of breastfeeding, y (Mean, SD) 0.7 (0.8)
Ever OC use (n, %) 633 (32.2%)
Duration of OC use, y (Mean, SD) 4.4 (4.4)
Age at menopause, y (Mean, SD) 50.4 (3.2)
Years since menopause, y (Mean, SD) 11.0 (5.2)
Hysterectomy (n, %) 346 (17.5%)
Unilateral oophorectomy (n, %) 127 (6.4%)
Ovulatory years (Mean, SD) 32.4 (5.2)
BMI at blood draw, kg/m2 (Mean, SD) 25.8 (4.7)
Smoking status (n, %)
 Never 885 (44.8%)
 Former 819 (41.5%)
 Current 272 (13.8%)
Alcohol (grams/day)
 No regular use 787 (41.7%)
 ≤20 964 (51.1%)
 >20 135 (7.2%)
Plasma hormone levels (median, 10th - 90th percentile, n)
 Estradiol (pg/mL) 5.0 (2.7–10.6), 1624
 Estrone (pg/mL) 22.9 (12.8–41.8), 1536
 Estrone sulfate (pg/mL) 230.4 (98.3–544.9), 1182
 Testosterone (ng/dL) 19.8 (10.4–37.5), 1869
 DHEAS (ug/dL) 61.2 (22.9–135.1), 1374
 Prolactin (ng/mL) 8.8 (5.3–15.6), 1192
 SHBG (nmol/L) 58.5 (28.1–103.1), 1779
*

Among parous women

Among women who ever breastfed

Among women who ever used OCs